Johnson & Johnson agreeing to pay $25 million after its subsidiary, McNeil, failed to initiate or complete the FDA’s corrective action plan for manufacturing issues that led to particles in bottles of children’s Tylenol is yet another reminder that the medicines we purchase for ourselves and our children are not always safe.
The FDA issued a new safety alert today regarding the potential danger of endoscopes, which are causing patients to develop serious and sometimes fatal infections, after re-use.
According to the New York Times, the FDA has never reviewed or approved the procedures manufacturers have recommended to sterilize duodenoscopes between patients.
Zofran is manufactured by GlaxoSmithKline and was granted FDA approval for use as an anti-nausea medication for cancer patients enduring chemotherapy treatments when it first came on the market.
The FDA is warning hospitals and surgeons against using laparoscopic power morcellators to remove uterine fibroids in most women.